Diagnostic performance of ADC for non-mass-like breast lesions on MR imaging

Magnetic Resonance in Medical Sciences

Volumn 9, Issue 4, 2010, Pages 217-225

  Imamura, Tsugumi ^a   Isomoto, Ichiro ^a   Sueyoshi, Eijun ^a   Yano, Hiroshi ^a   Uga, Tatsuya ^a   Abe, Kuniko ^b   Hayashi, Tomayoshi ^b   Honda, Sumihisa ^a   Yamaguchi, Takuma ^b   Uetani, Masataka ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Apparent diffusion coefficient; Breast; MRI; Non mass like lesion

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; BREAST; BREAST DISEASE; BREAST TUMOR; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; FEMALE; FOLLOW UP; HUMAN; IMAGE ENHANCEMENT; INTRADUCTAL CARCINOMA; METHODOLOGY; MIDDLE AGED; OBSERVER VARIATION; PAGET NIPPLE DISEASE; PATHOLOGY; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST DISEASES; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MIDDLE AGED; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 79955690627     PISSN: 13473182     EISSN: 18802206     Source Type: Journal    
DOI: 10.2463/mrms.9.217     Document Type: Article

References (33)

1. Harms SE, Flamig DP, Hesley KL, et al. MR imaging of the breast with rotating delivery of excitation oFF resonance: clinical experience with pathologic correlation. Radiology 1993; 187:493-501.
2. Orel SG, Schnall MD, LiVolsi VA, Troupin RH. Suspicious breast lesions: MR imaging with radiologic- pathologic correlation. Radiology 1994; 190: 485-493.
3. Boetes C, Barentsz JO, Mus RD, et al. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. Radiology 1994; 193:777-781.
4. Kuhl CK, Mielcareck P, Klaschik S, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999; 211:101-110.
5. American College of Radiology (ACR). Breast Imaging Reporting and Data System (BI-RADS), 4th ed. Reston, VA: American College of Radiology, 2003.
6. Jansen SA, Fan X, Karczmar GS, et al. DCEMRI of breast lesions: is kinetic analysis equally eFFective for both mass and nonmass-like enhancement? Med Phys 2008; 35:3102-3109.
7. Yabuuchi H, Matsuo Y, Kamitani T, et al. Nonmass- like enhancement on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diFFusion-weighted MR images. Eur J Radiol 2010; 75:e126-e132.
8. Partridge SC, DeMartini WB, Kurland BF, Eby PR, White SW, Lehman CD. Quantitative diffusion- weighted imaging as an adjunct to conventional breast MRI for important positive predictive value. AJR Am J Roentgenol 2009; 193:1716- 1722.
9. Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 1999; 213:881-888.
10. Liberman L, Morris EA, Lee MJ, et al. Breast lesions detected on MR imaging: features and positive predictive value. AJR Am J Roentgenol 2002; 179:171-178.
11. Yabuuchi H, Matsuo Y, Okafuji T, et al. Enhanced mass on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diFFusionweightedMR images. JMagn Reson Imaging 2008; 28:1157-1165.
12. Tozaki M, Fukuda K. High-spatial-resolution MRI of non-masslike breast lesions: interpretation model based on BI-RADS MRI descriptors. AJR Am J Roentgenol 2006; 187:330-337.
13. Tozaki M, Igarashi T, Fukuda K. Breast MRI using the VIBE sequence: clustered ring enhancement in the differential diagnosis of lesions showing nonmasslike enhancement. AJR Am J Roentgenol 2006; 187:313-321.
14. Sakamoto N, Tozaki M, Higa K, et al. Categorization of non-mass-like breast lesions detected by MRI. Breast Cancer 2008; 15:241-246.
15. Woodhams R, Matsunaga K, Iwabuchi K, et al. Diffusion-weighted imaging of malignant breast tumor: the usefulness of apparent diffusion coeficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J Comput Assist Tomogr 2005; 29:644-649.
16. Kuroki Y, Nasu K, Kuroki S, et al. DiFFusionweighted imaging of breast cancer with the sensitivity encoding technique: analysis of apparent diFFusion coefficient value. Magn Reson Med Sci 2004; 3:79-85.
17. Guo Y, Cai YQ, Cai ZL, et al. Differentiation of clinically benign and malignant breast lesions using diFFusion-weighted imaging. J Magn Reson Imaging 2002; 16:172-178.
18. Rubesova E, Grell AS, De Maertelaer V, Metens T, Chao SL, Lemort M. Quantitative diFFusion imaging in breast cancer: a clinical prospective study. J Magn Reson Imaging 2006; 24:319-324.
19. Hatakenaka M, Soeda H, Yabuuchi H, et al. Apparent diFFusion coefficients of breast tumors: clinical application. Magn Reson Med Sci 2008; 7:23-29.
20. Yoshikawa MI, Ohsumi S, Sugata S, et al. Relation between cancer cellularity and apparent diffusion coefficient values using diFFusion-weighted magnetic resonance imaging in breast cancer. Radiat Med 2008; 26:222-226.
21. Noguchi K, Watanabe N, Nagayoshi T, et al. Role of diffusion-weighted echo-planar MRI in distinguishing between brain abscess and tumour: a preliminary report. Neuroradiology 1999; 41: 171-174.
22. Ebisu T, Tanaka C, Umeda M, et al. Hemorrhagic and nonhemorrhagic stroke: diagnosis with diffusion- weighted and T2-weighted echo-planar MR imaging. Radiology 1997; 203:823-828.
23. Ebisu T, Tanaka C, Umeda M, et al. Discrimination of brain abscess from necrotic or cystic tumors by diFFusion-weighted echo planar imaging. Magn Reson Imaging 1996; 14:1113-1116.
24. Yuen S, Uematsu T, Masako K, Uchida Y, Nishimura T. Segmental enhancement on breast MR images: differential diagnosis and diagnostic strategy. Eur Radiol 2008; 18:2067-2075.
25. Jansen SA, Newstead GM, Abe H, Shimauchi A, Schmidt RA, Karczmar GS. Pure ductal carcinoma in situ: kinetic and morphologicMR characteristics compared with mammographic appearance and nuclear grade. Radiology 2007; 245:684-691.
26. Kuhl CK, Bieling HB, Gieseke J, et al. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclicalphase dependency. Radiology 1997; 203:137-144.
27. Ichikawa T, Erturk SM, Motosugi U, et al. High- B-value diFFusion-weighted MRI in colorectal cancer. AJR Am J Roentgenol 2006; 187:181-184.
28. Nakai G, Matsuki M, Inada Y, et al. Detection and evaluation of pelvic lymph nodes in patients with gynecologic malignancies using body diFFusionweighted magnetic resonance imaging. J Comput Assist Tomogr 2008; 32:764-768.
29. Sumi M, Sakihama N, Sumi T, et al. Discrimination of metastatic cervical lymph nodes with diFFusion-weighted MR imaging in patients with head and neck cancer. AJNR Am J Neuroradiol 2003; 24:1627-1634.
30. Heusner TA, Kuemmel S, Koeninger A, et al. Diagnostic value of diFFusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging. Eur J Nucl Med Mol Imaging 2010; 37:1077-1086.
31. Park MJ, Cha ES, Kang BJ, Ihn YK, Baik JH. The role of diFFusion-weighted imaging and the apparent diFFusion coefficient (ADC) values for breast tumors. Korean J Radiol 2007; 8(5):390-396.
32. Partridge SC, DeMartini WB, Kurland BF, Eby PR, White SW, Lehman CD. Differential diagnosis of mammographically and clinically occult breast lesions on diFFusion-weighted MRI. J Magn Reson Imaging 2010; 31:562-570.
33. Tozaki M, Fukuda K. Supine MR mammography using VIBE with parallel acquisition technique for the planning of breast-conserving surgery: clinical feasibility. Breast 2006; 15:137-140.